Predictive value of the serum bactericidal test for mortality in patients infected with multidrug-resistant Acinetobacter baumannii

Journal of Infection

Volumn 55, Issue 2, 2007, Pages 149-157

  Liao, Chun Hsing ^a,b   Sheng, Wang Huei ^a   Chen, Yee Chun ^a   Hung, Chien Ching ^a   Wang, Jann Tay ^a   Chang, Shan Chwen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Multidrug resistant Acinetobacter baumannii; Serum bactericidal test

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AZTREONAM; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; SULBACTAM; SULTAMICILLIN;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; MORTALITY; MULTIDRUG RESISTANCE; MULTIPLE ORGAN FAILURE; NONHUMAN; PREDICTION; PRESCHOOL CHILD; PROGNOSIS; SERUM BACTERICIDAL ACTIVITY; SURVIVAL RATE; TAIWAN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SERUM BACTERICIDAL TEST; SEVERITY OF ILLNESS INDEX; TAIWAN;

EID: 34447092062     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2007.01.015     Document Type: Article

References (32)

1. Gales A.C., Jones R.N., Forward K.R., Linares J., Sader H.S., and Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis 32 (2001) S104-S113
2. Gaynes R., Edwards J.R., and the National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 41 (2005) 848-854
3. Lortholary O., Fagon J.Y., Hoi A.B., Slama M.A., Pierre J., Giral P., et al. Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis 20 (1995) 790-796
4. Smolyakov R., Borer A., Riesenberg K., Schlaeffer F., Alkan M., Porath A., et al. Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment. J Hosp Infect 54 (2003) 32-38
5. Scerpella E.G., Wanger A.R., Armitige L., Anderlini P., and Ericsson C.D. Nosocomial outbreak caused by multiresistant clone of Acinetobacter baumannii: results of the case-control and molecular epidemiologic investigations. Infect Control Hosp Epidemiol 16 (1995) 92-97
6. Go E.S., Urban C., Burns J., Kreiswirth B., Eisner W., Mariano N., et al. Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 12 (1994) 1329-1332
7. Urban C., Segal-Maurer S., and Rahal J.J. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clin Infect Dis 36 (2003) 1268-1274
8. Hsueh P.R., Teng L.J., Chen C.Y., Chen W.H., Yu C.J., Ho S.W., et al. Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan. Emerg Infect Dis 8 (2002) 827-832
9. Wang S.H., Sheng W.H., Chang Y.Y., Wang L.H., Lin H.C., Chen M.L., et al. Healthcare-associated outbreak due to pan-drug resistant Acinetobacter baumannii in a surgical intensive care unit. J Hosp Infect 53 (2003) 97-102
10. Lee C.M., Lim H.K., Liu C.P., and Tseng H.K. Treatment of pan-drug resistant Acinetobacter baumannii. Scand J Infect Dis 37 (2005) 195-199
11. Kuo L.C., Yu C.J., Lee L.N., Wang J.L., Wang H.C., Hsueh P.R., et al. Clinical features of pandrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Taiwan. J Formos Med Assoc 102 (2003) 601-606
12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disc susceptibility. 7th ed. (2000), Approved standard, M2-A8. NCCLS, Wayne (PA) The Committee
13. Ko W.C., Lee H.C., Chiang S.R., Yan J.J., Wu J.J., Lu C.L., et al. In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strain. J Antimicrob Chemother 53 (2004) 393-395
14. Wang F.D., Lin M.L., Lee W.S., and Liu C.Y. In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria. Int J Antimicrob Agents 23 (2004) 590-595
15. Wolfson J.S., and Swartz M.N. Serum bactericidal test as a monitor of antibiotic therapy. N Eng J Med 312 (1985) 968-975
16. Klastersky J., Daneau D., Swings G., and Weerts D. Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections. J Infect Dis 129 (1974) 187-193
17. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th ed. (2000), Approved standard, M7-A6. NCCLS, Wayne (PA) The Committee
18. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement (2005), M100-S15. NCCLS, Wayne (PA)
19. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definition for nosocomial infections, 1988. Am J Infect Control 16 (1988) 128-140
20. McCabe W.R., and Jackson G.G. Gram-negative bacteremia, II: clinical, laboratory, and therapeutic observations. Arch Intern Med 110 (1962) 856-864
21. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101 (1992) 1644-1655
22. National Committee for Clinical Laboratory Standards. Methodology for the serum bactericidal test; approved guideline (1999), M21-A NCCLS, Wayne (PA)
23. MacGowan A., McMullin C., James P., Bowker K., Reeves D., and White L. External quality assessment of the serum bactericidal test: results of a methodology/interpretation questionnaire. J Antimicrob Chemother 39 (1997) 277-284
24. Simpson A.J., Dance D.A., Wuthiekanun V., and White N.J. Serum bactericidal and inhibitory titres in the management of melioidosis. J Antimicrob Chemother 45 (2000) 123-127
25. Tilley P.A., and Roberts F.J. Bacteremia with Acinetobacter species: risk factors and prognosis in different clinical settings. Clin Infect Dis 18 (1994) 896-900
26. Blot S., Vandewoude K., and Colardyn F. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Med 29 (2003) 471-475
27. Wisplinghoff H., Bischoff T., Tallent S.M., Seifert H., Wenzel R.P., and Edmond M.B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39 (2004) 309-317
28. Perl T.M., Dvorak L., Hwang T., and Wenzel R.P. Long-term survival and function after suspected gram-negative sepsis. JAMA 274 (1995) 338-345
29. Bates D.W., Pruess K.E., and Lee T.H. How bad are bacteremia and sepsis? Outcomes in a cohort with suspected bacteremia. Arch Intern Med 155 (1995) 593-598
30. Hacek D.M., Dressel D.C., and Peterson L.R. Highly reproducible bactericidal activity test results by using a modified National Committee for Clinical Laboratory Standards broth macrodilution technique. J Clin Microbiol 37 (1999) 1881-1884
31. Horrevorts A., Bergman K., Kollee L., Breuker I., Tjernberg I., and Dijkshoorn L. Clinical and epidemiological investigations of Acinetobacter genomospecies 3 in a neonatal intensive care unit. J Clin Microbiol 33 (1995) 1567-1572
32. Ecker J.A., Massire C., Hall T.A., Ranken R., Pennella T.T., Agasino Ivy C., et al. Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry. J Clin Microbiol 44 (2006) 2921-2932